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THE OBJECTIVE OF THE LECTURE
Coverage of modern concepts, the course and 
diagnostic of bronchial obstruction.
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INTRODUCTION
 Broncho-obstructive syndrome (BOS) is a pathological 
condition with airflow limitation during breathing. Approximately 
100 heterogeneous diseases are associated with BOS. In asthma 
and chronic obstructive pulmonary disease it is a leading clinical 
syndrome. Airway obstruction consists of reversible and 
irreversible components, with the inflammation as the main 
pathogenetic factor, developing under the influence of infectious, 
allergic, physical or neurogenic triggers. Moreover, the presence 
of viral or other respiratory infection deteriorates the course of 
bronchial obstruction, leading to the progression of the disease. 
 In most cases, BOS prognosis is serious and depends on the cause 
of bronchial obstruction, on the forms of the disease, timely 
conducted pathogenetic therapy and prevention.
http://www.ifp.kiev.ua/doc/journals/upj/19/pdf19-3/ref/32_en.pdf
THE URGENCY OF THE PROBLEM OF BOS
• In childhood, respiratory diseases occupy one of the first 
places.
• Hereditary factors, environmental pollution, social factors play 
an important role in it.
• In recent years there has been a marked increase in diseases that 
occur with an obstructive syndrome, which is very diverse in 
nature and may be a manifestation of many diseases.
• Manifestation of the syndrome usually occurs on the 
background of acute respiratory viral infection, it takes a severe 
course and is accompanied by signs of respiratory failure.
• Early diagnosis of the diseases that caused the obstruction, 
timely pathogenetic treatment and prevention reduces or 
eliminates clinical manifestations of the syndrome, and thus 
improves the quality of life of patients. 
https://www.scielo.br/scielo.php?pid=S0021-
75572015000800003&script=sci_arttext&tlng=en
THE SIGNIFICANCE OF THE PROBLEM OF 
BОS
• Inadequate diagnosis
• The lack of a comprehensive program of 
monitoring of the patients
• The lack of continuity of treatment in the hospital 
and continuing of treatment on an outpatient basis
• The need for rehabilitation and social adaptation
DEFINITION
 Bronchoobstructive syndrome (BOS) is a collective term 
that includes a number of symptoms of clinical 
manifestations of bronchial obstruction with underlying 
narrowing or occlusion of the airway. Clinically severe 
bronchoobstructive syndrome is most common in children, 
especially young children, but it is not a rare disease 
among the adult population. Its emergence and 
development is influenced by various factors, primarily 
respiratory viral infection. Early diagnosis and treatment of 
BOS in a therapeutic practice can significantly reduce the 
number of complications of the disease, improve survival 
and quality of life of patients.
https://therapy-journal.ru/en/archive/article/34481

• In Western literature this clinical symptom 
complex is currently called wheezing - wheezing 
syndrome. 
• The term "BOS" can not be used as an 
independent diagnosis. BOS is a symptom 
complex of any disease, the etiology of which is 
necessary to determine in all cases of the 
development of bronchial obstruction.
https://www.ncbi.nlm.nih.gov/books/NBK358/
• Bronchoobstructive syndrome lays in basis of 
asthma, bronchiectasis, bronchitis, chronic 
obstructive pulmonary disease (COPD), cystic 
fibrosis, etc.
https://en.wikipedia.org/wiki/Obstructive_lung_dis
ease /
CAUSES OF BOS
 Most often obstructive conditions occur in 
patients with a family history of allergies, 
especially, who often suffer from respiratory 
infections (more than 6 times). 
 Smoking including passive smoking (Chronic 
Obstructive Pulmonary Disease (COPD))
 Serious asthma symptoms with frequent 
exacerbations for a long time, which have not 
been improving with treatment 
 Long-term exposure to lung irritants (air pollution 
(industrial dust , chemical fumes, etc.)
https://www.webmd.com/lung/obstructive-and-
restrictive-lung-disease#2
CAUSES OF BOS
Preterm birth that leads to lung damage 
(neonatal chronic lung disease). 
 A family history of emphysema 
 Inherited factors (genes), including alpha-1 
antitrypsin deficiency
https://www.webmd.com/lung/obstructive-and-
restrictive-lung-disease#2
ETIOLOGY OF BOS
• Acute stenosing laryngotracheobronchitis of viral, bacterial 
and viral etiology of diphtheria.
• Peritonsillar abscess, retropharyngeal abscess, epiglotit, 
congenital stridor, hypertrophy of the tonsils and adenoids, 
cysts, hemangioma and papillomatosis of the larynx.
• In infants - aspiration caused by swallowing disorders, 
congenital abnormalities of the nasopharynx, chalasia and 
achalasia of the esophagus, tracheobronchial fistulas, 
gastroesophageal reflux disease. 
• Malformations of trachea, bronchi, respiratory distress 
syndrome (RDS), cystic fibrosis, bronchopulmonary
dysplasia, immunodeficiency, intrauterine infection
THE PATHOGENESIS OF BRONCHIAL 
OBSTRUCTION
depends on the etiology of the disease. Pathogenetic
mechanisms can be divided into two groups:
 1. Functional (reversible). It is bronchospasm, 
inflammatory infiltration, edema, violation of 
mucociliary clearance, hypersecretion.
 2. Irreversible (congenital stenosis of the bronchi 
and others).
https://pubmed.ncbi.nlm.nih.gov/8577106/
THE PATHOGENESIS OF BRONCHIAL 
OBSTRUCTION
• The main factor of the pathogenesis of 1 group BOS is 
inflammation, which can be both infectious and allergic.
• The mediator of the acute phase of inflammation is interleukin-
1 (IL-1).
• It is produced by phagocytic cells and tissue macrophages 
under the action of infection, allergy and promotes the release 
of first type mediators (histamine, serotonin) into peripheral 
blood.
• These mediators are constantly present in the granules of mast 
cells and basophils, that ensures very rapid biological effects.
• Besides histamine, an important role in the pathogenesis of 
inflammation is played by mediators of a second type 
(eicosanoids) generated during the early inflammatory 
response.
https://pubmed.ncbi.nlm.nih.gov/8577106/
THE PATHOGENESIS OF BRONCHIAL 
OBSTRUCTION
It is due to histamine, leukotrienes and anti-
inflammatory prostaglandins that we observe:
• enhancement of vascular permeability
• edema of bronchial mucosa
• hypersecretion of mucus viscous
• bronchoconstriction
https://pubmed.ncbi.nlm.nih.gov/8577106/
By duration, BOS can be:
• acute (BOS clinical manifestations persist for more than 10 days)
• protracted
• recurrent
• continuously recurring
According to the severity, the obstruction can be identified as:
• mild
• moderate
• severe
• latent bronchial obstruction
COMMON SYMPTOMS OF BOS
• prolonged exhale
• wheezing, noisy breathing (expiratory dyspnoea, BH 
50 and more per minute)
• asthmatic fits
• auxiliary muscles participating in breathing
• poorly productive cough
• decrease in oxygen partial pressure.
• depression and anxiety 
• weight loss 
• tiredness and fatigue 
• swollen ankles 
• limitations in activity and lifestyle
https://www.nhs.uk/conditions/chronic-obstructive-
pulmonary-disease-copd/symptoms/
MILD BOS
• wheezing on auscultation
• no breathlessness and cyanosis at rest 
• indices of blood gases are within the normal 
range
• external respiration function (ERF) indices are 
moderately reduced
• state of health of the patient, as a rule, does not 
suffer
https://www.researchgate.net/figure/Classification-of-airway-
obstruction_tbl2_268874757/
MODERATE SEVERITY OF BOS
• expiratory or mixed dyspnoea at rest
• cyanosis of nasolabial triangle
• indrawing of compliant places of the chest
• wheezing is audible at a distance
• ERF indices are reduced, but generalized 
functional bronchial obstruction is slightly broken 
(pa О2 is more than 60 mm Hg., pa СО2 is less 
than 45 mm Hg.)
https://www.researchgate.net/figure/Classification-of-airway-
obstruction_tbl2_268874757/
A SEVERE COURSE OF BOS
• state of health of the patient suffers
• it is characterized by noisy shortness of breath 
with auxiliary muscles participation
• presence of cyanosis
• ERF indices are sharply reduced
• There are signs of a generalized functional 
bronchial obstruction, pa О2 less than 60 mm Hg., 
pa СО2 more than 45 mm Hg.
https://www.researchgate.net/figure/Classification-of-airway-
obstruction_tbl2_268874757/
CONDITIONS OF BOS
Condition Main site Major changes Causes Symptoms
Chronic 
bronchitis
Bronchus Hyperplasia and 
hypersecretion
of mucus glands
Tobacco 
smoking and air 
pollutants 
Productive cough
Bronchiectasis Bronchus Dilation and 
scarring of 
airways
Persistent severe 
infections 
Cough, purulent 
sputum and 
fever
Asthma Bronchus Smooth muscle 
hyperplasia, 
excessive 
mucus, 
inflammation, 
constriction 
Immunologic or 
idiopathic 
Episodic 
wheezing, cough 
and dyspnea
Bronchiolitis
(subgroup of 
chronic 
bronchitis)
Bronchiole Inflammatory 
scarring and 
bronchiole 
obliteration
Tobacco 
smoking and air 
pollutants
Cough, dyspnea
https://en.wikipedia.org/wiki/Obstructive_lung_disease /
DIFFERENCE IN CONDITIONS OF BOS
 In asthma the bronchialtubes (airways) are 
hyperresponsive and usually triggered by breathing 
in things in the air such as dust, pollen, etc. with 
recurring episodes of wheezing, breathlessness, chest 
tightness, and coughing, particularly at night or in 
the early morning 
 Bronchiectasis refers to the abnormal, irreversible 
dilatation of the bronchi caused by destructive and 
inflammatory changes in the airway walls
 Chronic obstructive pulmonary disease (COPD) is 
characterized by airflow limitation that is not fully 
reversible.
http://www.meddean.luc.edu/lumen/MedEd/elective/pulmo
nary/bronchiectasis/bronchi_f.htm /

DIAGNOSTIC FUNCTION TESTS
 Spirometry is one type of pulmonary function test. Spirometry is 
a simple test to measure how much (volume) and how fast (flow) 
you can move air into and out of  your lungs.
https://www.nationaljewish.org/conditions/tests-procedures/pulmonary-
physiology/pulmonary-function/spirometry
https://www.informationisbeautifulawards.com/showcase/43
85-tailored-pamphlet-lung-function-test-results

https://www.nationaljewish.org/conditions/tests-procedures/pulmonary-
physiology/pulmonary-function/spirometry
FVC = forced vital capacity, FEV1 = forced expiratory volume in the first second 
of expiration
http://www.educatehealth.ca/media/443895/5-lightbox-investigation_and_workup-
copd-classification_by_impairment.png
DIAGNOSTIC FUNCTION TESTS
 The flow-volume loop is a plot of inspiratory and expiratory flow (on 
the Y-axis) against volume (on the X-axis) during the performance of 
maximally forced inspiratory and expiratory maneuvers. The patient is 
instructed to take a full inspiration (to total lung capacity), exhale 
forcefully and completely into the mouthpiece (to residual volume [RV]), 
and then inspire forcefully and fully back to total lung capacity. 
Typically, a flow-volume loop needs to be requested specifically, as an 
order for "spirometry" frequently yields just the expiratory portion. 
 The normal expiratory portion of the flow-volume curve is characterized 
by a rapid rise to the peak flow rate, followed by a nearly linear fall in 
flow as the patient exhales toward RV . The inspiratory curve, in 
contrast, is a relatively symmetrical, saddle-shaped curve. The flow rate 
at the midpoint of vital capacity (between total lung capacity and 
residual volume), known as the forced expiratory flow-50 (FEF50), is 
normally slightly less than the flow rate at the midpoint of inspiration, 
known as the forced inspiratory flow-50 (FIF50). Thus, the ratio 
FEF50/FIF50 is normally <1. https://www.uptodate.com/contents/flow-volume-loops
https://www.lungfunction.com.au/flow-volume-loops.html
DIAGNOSTIC FUNCTION TESTS
 Chest X-rays can detect 
cancer, infection or air 
collecting in the space 
around a lung, which can 
cause the lung to collapse. 
They can also show chronic 
lung conditions, such as 
emphysema or cystic 
fibrosis, as well as 
complications related to 
these conditions.
https://www.mayoclinic.org/tests-procedures/chest-x-
rays/about/pac-20393494
https://medicalxpress.com/news/2014-12-chest-x-rays-
children-unnecessary.html
DIAGNOSTIC FUNCTION TESTS
 An arterial blood gas (ABG) is a blood test that 
measures the acidity, or pH, and the levels of 
oxygen (O2) and carbon dioxide (CO2) from an 
artery. The test is used to check the function of 
the patient’s lungs and how well they are able to 
move oxygen into the blood and remove carbon 
dioxide. This test is commonly performed in the 
ICU and ER setting; however, ABGs can be 
drawn on any patient on any floor depending on 
their diagnosis.
https://nurse.org/articles/arterial-blood-gas-
test/#:~:text=What%20is%20an%20Arterial%20Blood,blood%2
0and%20remove%20carbon%20dioxide.
 PaO2 (measured in mmHg or kPa) is an accurate 
reflection of the ability of the lungs to transfer 
oxygen to the blood. A low PaO2 represents 
hypoxaemia and can initiate hyperventilation. 
https://veteriankey.com/blood-gas-acid-base-analysis-and-
electrolyte-abnormalities/.
 PaCO2 (in mmHg or kPa) indicates the 
effectiveness of alveolar ventilation. Alveolar 
ventilation determines PaCO2. Hyperventilation 
results in a decreased PaCO2 (hypocapnia), 
whereas hypoventilation increases PaCO2 
(hypercapnia). Changes in ventilation may occur 
in patients with primary pulmonary disease, 
central nervous system (CNS) impairment, or 
may occur as a compensatory change in patients 
with metabolic disturbances.
https://veteriankey.com/blood-gas-acid-base-analysis-and-
electrolyte-abnormalities/.
 The SaO2 (pulse 
oximeter) measures the 
percentage of 
haemoglobin actually 
carrying oxygen, which 
is why 95–100% is 
normal.
 The test can be useful 
in finding out whether 
oxygen treatment is 
needed, but it provides 
less information than 
the arterial blood gas 
test.
DIFFERENCE BETWEEN ABG & OXIMETRY
https://www.semanticscholar.org/paper/Pulse-oximetry-versus-
arterial-blood-gas-specimens-
Pierson/f68931756ce866a682416ba0066a79fda60f2faa
ELECTROCARDIOGRAM FEATURES
 ECG changes occur in Chronic Obstructive 
Pulmonary Disease (COPD) due to:
 The presence of hyperexpanded emphysematous 
lungs within the chest.
 The long-term effects of hypoxic pulmonary 
vasoconstriction upon the right side of the heart, 
causing pulmonary hypertension and subsequent 
right atrial and right ventricular hypertrophy (i.e. 
cor pulmonale).
https://litfl.com/ecg-in-chronic-obstructive-pulmonary-disease/
ECG demonstrates many of the features of chronic pulmonary disease:
 Rightward QRS axis (+90 degrees).
 Peaked P waves in the inferior leads > 2.5 mm (P pulmonale) with a rightward 
P-wave axis (inverted in aVL)
 Clockwise rotation of the heart with a delayed R/S transition point (transitional 
lead = V5).
 Absent R waves in the right precordial leads (SV1-SV2-SV3 pattern).
 Low voltages in the left-sided leads (I, aVL, V5-6).
https://litfl.com/ecg-in-chronic-obstructive-pulmonary-disease/
 This ECG shows multifocal atrial tachycardia with additional features 
of COPD:
 Rapid, irregular rhythm with multiple P-wave morphologies (best seen 
in the rhythm strip).
 Right axis deviation, dominant R wave in V1 and deep S wave in V6 
suggest right ventricular hypertrophy due to cor pulmonale.
https://litfl.com/ecg-in-chronic-obstructive-pulmonary-disease/
DIFFUSING CAPACITY OF THE LUNGS
 A test of the diffusing capacity of the lungs for 
carbon monoxide (DLCO, also known as transfer 
factor for carbon monoxide or TLCO), is one of the 
most clinically valuable tests of lung function.
 The DLCO measures the ability of the lungs to 
transfer gas from inhaled air to the red blood cells in 
pulmonary capillaries. The DLCO test is convenient 
and easy for the patient to perform. The ten seconds 
of breathholding required for the DLCO maneuver is 
easier for most patients to perform than the forced 
exhalation required for spirometry.
https://www.uptodate.com/contents/diffusing-capacity-for-carbon-
monoxide#:~:text=DLCO%20%E2%80%93%20The%20diffusing%20capac
ity%20for,to%20the%20red%20blood%20cells.&text=It%20is%20an%20in
dex%20of,alveolar%20transfer%20of%20carbon%20monoxide. /
 The following division is frequently employed in 
clinical practice for the assessment of a reduction 
of transfer factor:
http://lungfunction.net/basics/transfer-factor.htm
COMPUTED TOMOGRACHY OF THE LUNGS
Computed tomography (CT) allows for early 
detection of emphysema. CT also makes it possible to 
quantify the total amount of emphysema in the lungs 
which is important in order to precisely estimate the 
severity of the disease. Those abilities of CT are 
important in monitoring the course of the disease and 
in attempts to prevent its further progression.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389962/
SURVEILLANCE & PREVENTION OF BOS
 National surveillance systems should primarily focus on 
monitoring the following, bearing in mind the importance 
of developing and implementing simple methodologies for 
providing objective measures of trends:
- cause specific mortality;
- risk factor prevalence;
- certain morbidity data like hospital admissions and 
consultations due to common respiratory conditions, as 
well as therapeutic trends.
 Standard indicators should be adopted. These may include 
lung function measurements, disease progression, 
absenteeism from school or work, and hospitalisations.
https://www.who.int/respiratory/publications/strategy/en/index5.html
https://www.who.int/respiratory/publications/strategy/en/index5.html
https://www.who.int/respiratory/publications/strategy/en/index5.html
